CSE: MVMD
OTC: MVMDF
Home
Our Mission
Our Mission (Coming Soon)
Technology
Investor
Media Releases
CEO Updates
FAQ
Contact
#MORELIFE
Home
Our Mission
Technology
Investor
Media Releases
CEO Updates
FAQ
Contact
Investor
Ceo Updates
Current Post
Posted On:
Friday, October 2, 2020
Mountain Valley MD confirms successful Quicksome™ dosing in pre-clinical trial for the drug ivermectin
Regards,
Dennis Hancock
President & CEO, Mountain Valley MD
Subscribe to Updates from MVMD
Stay plugged in on everything MVMD.
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
*By Clicking "Sign Up" You agree to Mountain Valley MD's
Privacy Policy